Figure 1.
MRONJ risk profile of patients with metabolic bone fragility receiving AR medications [19]. * It includes also CTIBL patients (hormone deprivation therapy induced bone loss in breast and prostate cancer patients without bone metastases).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.